ID   HNF4A_RAT               Reviewed;         474 AA.
AC   P22449; A2ICG9;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 3.
DT   24-JUL-2024, entry version 208.
DE   RecName: Full=Hepatocyte nuclear factor 4-alpha;
DE            Short=HNF-4-alpha;
DE   AltName: Full=Nuclear receptor subfamily 2 group A member 1;
DE   AltName: Full=Transcription factor 14;
DE            Short=TCF-14;
DE   AltName: Full=Transcription factor HNF-4;
GN   Name=Hnf4a; Synonyms=Hnf-4, Hnf4, Nr2a1, Tcf14;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=2279702; DOI=10.1101/gad.4.12b.2353;
RA   Sladek F.M., Zhong W., Lai E., Darnell J.E. Jr.;
RT   "Liver-enriched transcription factor HNF-4 is a novel member of the steroid
RT   hormone receptor superfamily.";
RL   Genes Dev. 4:2353-2365(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND ALTERNATIVE SPLICING.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=1610903; DOI=10.1016/0167-4781(92)90080-j;
RA   Hata S., Tsukamoto T., Osumi T.;
RT   "A novel isoform of rat hepatocyte nuclear factor 4 (HNF-4).";
RL   Biochim. Biophys. Acta 1131:211-213(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21-378 (ISOFORMS LONG AND SHORT).
RC   STRAIN=New England Deaconess Hospital; TISSUE=Liver;
RA   Huang J., Karakucuk V., Levitsky L.L., Rhoads D.B.;
RT   "Expression of HNF4 alpha 3 in pancreatic islets and Ins-1 beta cells.";
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   MUTAGENESIS, AND PHOSPHORYLATION AT SER-142 AND SER-143.
RX   PubMed=9234678; DOI=10.1128/mcb.17.8.4208;
RA   Viollet B., Kahn A., Raymondjean M.;
RT   "Protein kinase A-dependent phosphorylation modulates DNA-binding activity
RT   of hepatocyte nuclear factor 4.";
RL   Mol. Cell. Biol. 17:4208-4219(1997).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-432 AND SER-436, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 142-391, FATTY ACID BINDING, AND
RP   SUBUNIT.
RX   PubMed=12193589; DOI=10.1074/jbc.c200420200;
RA   Dhe-Paganon S., Duda K., Iwamoto M., Chi Y.I., Shoelson S.E.;
RT   "Crystal structure of the HNF4 alpha ligand binding domain in complex with
RT   endogenous fatty acid ligand.";
RL   J. Biol. Chem. 277:37973-37976(2002).
CC   -!- FUNCTION: Transcriptional regulator which controls the expression of
CC       hepatic genes during the transition of endodermal cells to hepatic
CC       progenitor cells, facilitating the recruitment of RNA pol II to the
CC       promoters of target genes (By similarity). Activates the transcription
CC       of CYP2C38 (By similarity). Represses the CLOCK-BMAL1 transcriptional
CC       activity and is essential for circadian rhythm maintenance and period
CC       regulation in the liver and colon cells (By similarity).
CC       {ECO:0000250|UniProtKB:P41235, ECO:0000250|UniProtKB:P49698}.
CC   -!- SUBUNIT: Homodimerization is required for HNF4-alpha to bind to its
CC       recognition site (PubMed:12193589). Interacts with CLOCK, BMAL1, CRY1,
CC       CRY2, PER1 and PER2 (By similarity). Interacts with NR0B2/SHP; the
CC       resulting heterodimer is transcriptionally inactive (By similarity).
CC       Interacts with DDX3X; this interaction disrupts the interaction between
CC       HNF4 and NR0B2 that forms inactive heterodimers and enhances the
CC       formation of active HNF4 homodimers (By similarity).
CC       {ECO:0000250|UniProtKB:P41235, ECO:0000269|PubMed:12193589}.
CC   -!- INTERACTION:
CC       P22449; P02692: Fabp1; NbExp=3; IntAct=EBI-5261592, EBI-1209448;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P22449-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P22449-2; Sequence=VSP_003677;
CC   -!- TISSUE SPECIFICITY: Liver, kidney and intestine.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P41235}.
CC   -!- PTM: Phosphorylation at Ser-313 by AMPK reduces the ability to form
CC       homodimers and bind DNA (By similarity). Phosphorylated in the
CC       recognition sequence R-R-S-S near the DNA-binding domain;
CC       phosphorylation results in decrease in DNA-binding activity.
CC       Phosphorylation of HNF4 depends on the diet and is decreased by a
CC       carbohydrate-rich diet and is increased by fasting. {ECO:0000250,
CC       ECO:0000269|PubMed:9234678}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Acetylation at Lys-458 lowers transcriptional activation by about
CC       two-fold. {ECO:0000250}.
CC   -!- MISCELLANEOUS: DNA-binding activity of phosphorylated protein is
CC       reduced by fasting and by inducers of intracellular cyclic AMP.
CC   -!- MISCELLANEOUS: Binds fatty acids.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR2
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA01411.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA40412.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D10554; BAA01411.1; ALT_INIT; mRNA.
DR   EMBL; X57133; CAA40412.1; ALT_INIT; mRNA.
DR   EMBL; EF193392; ABM69090.1; -; mRNA.
DR   PIR; A36471; A36471.
DR   PIR; S23502; S23502.
DR   RefSeq; NP_071516.2; NM_022180.2.
DR   PDB; 1M7W; X-ray; 2.80 A; A/B/C/D=142-391.
DR   PDBsum; 1M7W; -.
DR   AlphaFoldDB; P22449; -.
DR   SMR; P22449; -.
DR   BioGRID; 247763; 1.
DR   IntAct; P22449; 2.
DR   MINT; P22449; -.
DR   STRING; 10116.ENSRNOP00000071432; -.
DR   ChEMBL; CHEMBL3714705; -.
DR   iPTMnet; P22449; -.
DR   PhosphoSitePlus; P22449; -.
DR   PaxDb; 10116-ENSRNOP00000011978; -.
DR   GeneID; 25735; -.
DR   KEGG; rno:25735; -.
DR   AGR; RGD:2810; -.
DR   CTD; 3172; -.
DR   RGD; 2810; Hnf4a.
DR   eggNOG; KOG4215; Eukaryota.
DR   InParanoid; P22449; -.
DR   OrthoDB; 5400963at2759; -.
DR   PhylomeDB; P22449; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   EvolutionaryTrace; P22449; -.
DR   PRO; PR:P22449; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0050544; F:arachidonic acid binding; IDA:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:BHF-UCL.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0005504; F:fatty acid binding; IPI:RGD.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IPI:RGD.
DR   GO; GO:0036042; F:long-chain fatty acyl-CoA binding; IDA:RGD.
DR   GO; GO:0052816; F:long-chain fatty acyl-CoA hydrolase activity; IDA:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IMP:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0070540; F:stearic acid binding; IDA:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0001221; F:transcription coregulator binding; IPI:BHF-UCL.
DR   GO; GO:0001222; F:transcription corepressor binding; IPI:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; IDA:RGD.
DR   GO; GO:0007596; P:blood coagulation; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IMP:RGD.
DR   GO; GO:0045216; P:cell-cell junction organization; IDA:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0007164; P:establishment of tissue polarity; IDA:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0070365; P:hepatocyte differentiation; IEP:RGD.
DR   GO; GO:0055088; P:lipid homeostasis; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IDA:RGD.
DR   GO; GO:0042308; P:negative regulation of protein import into nucleus; IDA:RGD.
DR   GO; GO:0042532; P:negative regulation of tyrosine phosphorylation of STAT protein; IDA:RGD.
DR   GO; GO:0006591; P:ornithine metabolic process; ISO:RGD.
DR   GO; GO:0055091; P:phospholipid homeostasis; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:BHF-UCL.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0045722; P:positive regulation of gluconeogenesis; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010470; P:regulation of gastrulation; ISO:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISO:RGD.
DR   GO; GO:0032534; P:regulation of microvillus assembly; IMP:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; IDA:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0035983; P:response to trichostatin A; IDA:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0007548; P:sex differentiation; ISO:RGD.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0070328; P:triglyceride homeostasis; ISO:RGD.
DR   GO; GO:0006805; P:xenobiotic metabolic process; ISO:RGD.
DR   CDD; cd06960; NR_DBD_HNF4A; 1.
DR   CDD; cd06931; NR_LBD_HNF4_like; 1.
DR   DisProt; DP02610; -.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR049636; HNF4-like_DBD.
DR   InterPro; IPR049635; HNF4_LBD.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050274; Nuclear_hormone_rcpt_NR2.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR24083:SF41; HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; 1.
DR   PANTHER; PTHR24083; NUCLEAR HORMONE RECEPTOR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01282; COUPTNFACTOR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Biological rhythms; Direct protein sequencing; DNA-binding;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Receptor;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..474
FT                   /note="Hepatocyte nuclear factor 4-alpha"
FT                   /id="PRO_0000053560"
FT   DOMAIN          147..377
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        57..132
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         60..80
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         96..120
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          413..450
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           368..376
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   MOD_RES         142
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000305|PubMed:9234678"
FT   MOD_RES         143
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000305|PubMed:9234678"
FT   MOD_RES         144
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   MOD_RES         166
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   MOD_RES         313
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   MOD_RES         429
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   MOD_RES         432
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         436
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         458
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   CROSSLNK        234
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   CROSSLNK        307
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P41235"
FT   VAR_SEQ         418..428
FT                   /note="CEWPRPRGQAA -> S (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:1610903, ECO:0000303|Ref.3"
FT                   /id="VSP_003677"
FT   MUTAGEN         142..143
FT                   /note="SS->AG: Loss of phosphorylation, no effect on DNA-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9234678"
FT   MUTAGEN         142..143
FT                   /note="SS->LE: Loss of phosphorylation, no effect on DNA-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9234678"
FT   CONFLICT        180
FT                   /note="K -> R (in Ref. 1; CAA40412)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        183
FT                   /note="N -> S (in Ref. 1; CAA40412)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        378
FT                   /note="S -> L (in Ref. 3; ABM69090)"
FT                   /evidence="ECO:0000305"
FT   HELIX           152..164
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           184..203
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           206..209
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           213..222
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           224..234
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   TURN            235..238
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   STRAND          239..244
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   STRAND          250..254
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           256..258
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   TURN            259..261
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           262..271
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           273..279
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           283..294
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           305..324
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   STRAND          326..328
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           333..338
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           341..360
FT                   /evidence="ECO:0007829|PDB:1M7W"
FT   HELIX           368..373
FT                   /evidence="ECO:0007829|PDB:1M7W"
SQ   SEQUENCE   474 AA;  52712 MW;  E6DECA74FEA65E75 CRC64;
     MRLSKTLADM DMADYSAALD PAYTTLEFEN VQVLTMGNDT SPSEGANLNS SNSLGVSALC
     AICGDRATGK HYGASSCDGC KGFFRRSVRK NHMYSCRFSR QCVVDKDKRN QCRYCRLKKC
     FRAGMKKEAV QNERDRISTR RSSYEDSSLP SINALLQAEV LSQQITSPIS GINGDIRAKK
     IANITDVCES MKEQLLVLVE WAKYIPAFCE LLLDDQVALL RAHAGEHLLL GATKRSMVFK
     DVLLLGNDYI VPRHCPELAE MSRVSIRILD ELVLPFQELQ IDDNEYACLK AIIFFDPDAK
     GLSDPGKIKR LRSQVQVSLE DYINDRQYDS RGRFGELLLL LPTLQSITWQ MIEQIQFIKL
     FGMAKIDNLL QEMLLGGSAS DAPHAHHPLH PHLMQEHMGT NVIVANTMPS HLSNGQMCEW
     PRPRGQAATP ETPQPSPPSG SGSESYKLLP GAITTIVKPP SAIPQPTITK QEAI
//
